Skip to main content
Clinical Trials/NL-OMON45509
NL-OMON45509
Recruiting
Not Applicable

Identifying Rheumatoid Arthritis in the preclinical phase - Extension of the observational Leiden Clinically Suspect Arthralgia (CSA) cohort in the Medical Delta to enable sufficiently powered studies with the ultimate aim to arrive at proper accuracy to identify imminent Rheumatoid Arthritis. - Identifying Rheumatoid Arthritis in the preclinical phase

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
rheumatoid arthritis
Sponsor
Erasmus MC, Universitair Medisch Centrum Rotterdam
Enrollment
600
Status
Recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Observational non invasive

Investigators

Eligibility Criteria

Inclusion Criteria

  • \- Arthralgia on hand, wrist or feet joints that is according to the rheumatologist clinical suspect to become RA (e.g. because of an inflammatory type or the presence of morning stiffness)
  • \- Recent onset of complaints (\< 1 year)
  • \- Age \> 18 years
  • \- Written informed consent

Exclusion Criteria

  • A potential subject who meets any of the following criteria will be excluded from participation in this study as this precludes the presence of CSA:
  • \- Presence of, or history of, clinically apparent arthritis
  • \- Previous or current treatment with DMARDs or corticosteroids
  • \- If another condition or explanation for the pain is more likely (other than imminent RA), a patient does not have CSA

Outcomes

Primary Outcomes

Not specified

Similar Trials